Lv1
90 积分 2025-02-08 加入
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine
1天前
已完结
CDCP1-Targeting ADC Outperforms Standard Therapies in Ras-Mutant Pancreatic Cancer
1天前
已完结
Evaluation of PNU-159682 antibody drug conjugates (ADCs)
1天前
已完结
The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models
1天前
已完结
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
6天前
已完结
Preclinical Characterization of the Distribution, Catabolism, and Elimination of a Polatuzumab Vedotin-Piiq (POLIVY®) Antibody–Drug Conjugate in Sprague Dawley Rats
7天前
已完结
Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin
7天前
已完结
Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
7天前
已完结
Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence
7天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
8天前
已完结
皖公网安备34019202002308
